FDA Weighs the Risks of Rituxan - WSJ.com
Links shared publicly online about this topic.
- 2,003total visits
FDA Weighs the Risks of Rituxan - WSJ.com
View full resource at online.wsj.com
Tags: Cancer, Cancer Medication, Non-Hodgkin Lymphoma Medication, Rheumatoid Arthritis Medication, Disease and Condition, Drug, FDA, Rituxan
Most Recently Shared on June 1, 2009 at 12:52 am By:
FDA Weighs the Risks of Rituxan http://tinyurl.com/nexw2d
#FDA to Weigh Safety of #Tobacco Lozenges, Strips http://t.co/aHMSa0K9
health.childrenscentralcal.org — “Experts fear candy-like products could put children at risk for nicotine addiction, poisoning” View full resource at health.childrenscentralcal.org
Most Recently Shared on January 18, 2012 at 10:00 pm By:
Children's Hospital Hospital and Children's Hospital
#FDA to Weigh Safety of #Tobacco Lozenges, Strips http://t.co/aHMSa0K9
FDA to weigh safety of tobacco lozenges, strips - USATODAY.com
yourlife.usatoday.com — “The safety and risks of "dissolvables" are the subject of a three-day U.S. Food and Drug Administration meeting this week.” View full resource at yourlife.usatoday.com
Most Recently Shared on January 18, 2012 at 6:59 pm By:
Safe Kids USA Health Organization
Parents & caregivers - if you use smokeless tobacco products be sure to keep away from children! http://t.co/DvZFkiXK @USAToday #FDA
5 Things You Should Know About the Birth Control-Blood Clot Connection - Sexual Health Center - EverydayHealth.com
everydayhealth.com — “FDA weighed that the benefits of birth control pills like Yaz outweigh the risks, but many women are still worried about their safety. Here's what you should know.” View full resource at everydayhealth.com
Most Recently Shared on December 22, 2011 at 12:15 pm By:
5 things you should know about the birth control-blood clot connection http://t.co/mt6N8XHp
5 Things You Should Know About the Birth Control-Blood Clot Connection - Sexual Health Center - EverydayHealth.com
everydayhealth.com — “FDA weighed that the benefits of birth control pills like Yaz outweigh the risks, but many women are still worried about their safety. Here's what you should know.” View full resource at everydayhealth.com
Most Recently Shared on December 18, 2011 at 1:27 pm By:
DrRobertGreene Reproductive Endocrinologist, Physician, Doctor, ObGyn Physician, and Surgeon
5 Things You Should Know About the Birth Control-Blood Clot Connection - http://t.co/sVUtyl8N Fair & balances summary of the latest info
Medical News: FDA Panel to Weigh Break from Bisphosphonate Use - in Endocrinology, Osteoporosis from MedPage Today
medpagetoday.com — “WASHINGTON -- A joint FDA advisory committee will meet Friday to discuss the risks associated with long-term use of bisphosphonates and whether a drug holiday would help prevent fractures in patient” View full resource at medpagetoday.com
Most Recently Shared on September 15, 2011 at 10:56 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Medical News: FDA Panel to Weigh Break from Bisphosphonate Use - http://t.co/LRpsHfxK from @medpagetoday #health #medicine
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on August 16, 2011 at 8:23 pm By:
FDA tries to clarify how it weighs risk vs benefit http://t.co/DiL6RMd
Pfizer Addiction Pill Weighed by FDA After 72% Added Heart Risk - Bloomberg
bloomberg.com — “Pfizer Inc.’s anti-smoking pill Chantix may receive new warnings from U.S. regulators after a study released today found the drug increased the risk of hospitalizations for heart problems by 72 percent.” View full resource at bloomberg.com
Most Recently Shared on July 5, 2011 at 3:15 pm By:
Thomas Concannon Doctor, Research, and PhD
Pfizer Addiction Pill Weighed by FDA After 72% Added Heart Risk - Bloomberg http://t.co/uUpA03t via @BloombergNews
FDA warns against epilepsy drug valproate for pregnant women - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA, in a warning issued Thursday, said that women who took valproate products for epilepsy and psychiatric problems during pregnancy increased the risk that their babies would have developmental delays, compared with women who took other anti-seizure drugs. Medical providers should "weigh the …” View full resource at smartbrief.com
Most Recently Shared on July 1, 2011 at 6:49 pm By:
Adam Palazzari, MD Internist, Physician, Doctor, and Pediatrician
FDA warns against epilepsy drug valproate for pregnant women http://t.co/qLrqWJY
FDA Recommends More Conservative Dosing of ESAs - Larry Husten - Cardiobrief - Forbes
blogs.forbes.com — “The FDA today said that it was recommending more conservative dosing of ESAs (erythropoiesis-stimulating agents) in patients with chronic kidney disease (CKD). The possible beneficial effects of the drugs to decrease the need for transfusions in CKD patients should be weighed against the increased risk of cardiovascular events, the FDA [...]” View full resource at blogs.forbes.com
Most Recently Shared on June 24, 2011 at 5:41 pm By:
Drugs and Devices OW OW Health
FDA Recommends More Conservative Dosing of ESAs: The FDA today said that it was recommending more conse... http://onforb.es/j8WpHG #drug
Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy | Health Policy and Reform
healthpolicyandreform.nejm.org — “Amy Egan, M.D., M.P.H., and Eric Colman, M.D. Statins are the most widely prescribed class of drugs for treating dyslipidemia — in particular, elevated” View full resource at healthpolicyandreform.nejm.org
Most Recently Shared on June 16, 2011 at 1:24 am By:
Physician Assistants Health News Feed
Weighing Benefits of High-Dose Simvastatin against the Risk of Myopathy: http://bit.ly/lHvmmC FDA will closely monitor prescription-use data
U.S. Weighs Cancer Risk of Styrene and Formaldehyde - NYTimes.com
nytimes.com — “The government is expected to add the ubiquitous chemical styrene — found in building materials and food and drink containers, among other places — to its list of likely carcinogens.” View full resource at nytimes.com
Most Recently Shared on June 15, 2011 at 3:38 pm By:
LHJ Health Editors Health Communicator
I worked in offices for years with those styrofoam coffee cups. You? FDA deems them carcinogens: http://t.co/ORIQoia
FDA Evaluates New Studies on Risk of Birth Control Medications Like Yaz
usrecallnews.com — “Birth control medications that contain drospirenone, such as widely-used brands Yasmin and Yaz, have yet to be officially recalled, but given mounting scientific evidence, it appears the FDA is carefully weighing the matter.” View full resource at usrecallnews.com
Most Recently Shared on June 9, 2011 at 7:31 pm By:
FDA Evaluates New Studies on Risk of Birth Control Medications Like Yaz http://p.ost.im/p/THHp3
FDA weighs in favor of olmesartan
endocrinetoday.com — “In the wake of results from two trials, the FDA has determined that the benefits of olmesartan continue to outweigh the potential risks for the” View full resource at endocrinetoday.com
Most Recently Shared on April 15, 2011 at 3:47 pm By:
#FDA weighs in favor of #olmesartan http://bit.ly/hQsHE7
Weight Loss Drug Qnexa - ABC News
abcnews.go.com — “The FDA rejected an application from drug maker Vivus to have Qnexa approved for the treatment of obesity, citing possible health risks. But the results of a phase 3 clinical trial reveal the magnitude of benefit.” View full resource at abcnews.go.com
Most Recently Shared on April 11, 2011 at 10:55 am By:
Susan Scroggins Health Advocate and Active Health Library
Weighing Risks, Benefits of Diet Drugs: Qnexa helped some shed 10 percent of their weight, but the FDA still nix... http://bit.ly/ecb2vJ
FDA warns of birth defects with Topamax
washingtonpost.com — “FDA says data show increased risk of cleft lip in children whose mothers take epilepsy drug” View full resource at washingtonpost.com
Most Recently Shared on March 6, 2011 at 10:29 pm By:
Yvette Vignando Parenting Supporter
Epilepsy drug Topamax - possible link with certain birth defects but need to weigh up benefits and risks http://wapo.st/fZeISH
Advertisement
